The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Perspective Therapeutics Inc’s stock clocked out at $2.45, down -5.77% from its previous closing price of $2.60. In other words, the price has decreased by -$5.77 from its previous closing price. On the day, 0.78 million shares were traded. CATX stock price reached its highest trading level at $2.615 during the session, while it also had its lowest trading level at $2.3732.
Ratios:
To gain a deeper understanding of CATX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.60 and its Current Ratio is at 9.60. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
BofA Securities Downgraded its Buy to Neutral on November 25, 2024, whereas the target price for the stock was revised from $24 to $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 04 ’24 when HENSON HEIDI bought 25,975 shares for $3.85 per share. The transaction valued at 100,004 led to the insider holds 25,975 shares of the business.
Spoor Johan M. bought 8,000 shares of CATX for $30,132 on Dec 04 ’24. The CEO now owns 36,257 shares after completing the transaction at $3.77 per share. On Nov 25 ’24, another insider, Williamson Robert F III, who serves as the Director of the company, bought 6,266 shares for $3.64 each. As a result, the insider paid 22,814 and bolstered with 430,058 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 165589392 and an Enterprise Value of -97989528. Its current Enterprise Value per Revenue stands at -62.935 whereas that against EBITDA is 1.757.
Stock Price History:
The Beta on a monthly basis for CATX is 1.13, which has changed by -0.79583335 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $19.05, while it has fallen to a 52-week low of $2.32. The 50-Day Moving Average of the stock is -21.22%, while the 200-Day Moving Average is calculated to be -72.46%.
Shares Statistics:
It appears that CATX traded 862.05K shares on average per day over the past three months and 504500 shares per day over the past ten days. A total of 67.56M shares are outstanding, with a floating share count of 49.26M. Insiders hold about 27.12% of the company’s shares, while institutions hold 74.73% stake in the company. Shares short for CATX as of 1740700800 were 5909500 with a Short Ratio of 6.86, compared to 1738281600 on 5417505. Therefore, it implies a Short% of Shares Outstanding of 5909500 and a Short% of Float of 10.6400006.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
